Archita Kukreja
M.B.A., M.S., Lead Healthcare Research & Data Analyst
Archita has authored reports on hematological indications like beta thalassemia and sickle cell disease, infectious diseases and several niche and rare indications. Prior to joining Clarivate, she was a Manager at Sanofi. She has worked on diverse custom and syndicated research project types in several therapeutic areas and has experience in sales- and epidemiology-based forecasting, demand forecasting, commercial opportunity assessments, and market intelligence. She holds double master’s degrees in business administration (M.B.A) and in Science (M.S.) with specialization in Biotechnology from Amity University, Noida, India and Jamia Millia Islamia University, Delhi, India, respectively.
Latest news
Clarivate Identifies Five Medtech Trends Set to Redefine Growth Opportunities in 2026
New Medtech Trends to Watch report highlights market shifts, care delivery changes and competitive dynamics poised to reshape medtech strategy London, U.K. May 13, 2026. Clarivate Plc (NYSE:CLVT), a leading…